Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 3902 results
Sort by: relevance publication year
Showing results for ISSN matching 1170-7690

Quality-of-Life Instruments for Severe Chronic Mental Illness

JOURNAL ARTICLE published March 1995 in PharmacoEconomics

Authors: Marion Becker

https://doi.org/10.2165/00019053-199507030-00006 Actions

Trends in Outpatient Prescription Drug Use and Related Costs in the US

JOURNAL ARTICLE published 2006 in PharmacoEconomics

Authors: Diane K Wysowski | Laura A Governale | Joslyn Swann

https://doi.org/10.2165/00019053-200624030-00003 Actions

Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment

JOURNAL ARTICLE published January 2018 in PharmacoEconomics

Authors: Jaclyn Beca | Don Husereau | Kelvin K. W. Chan | Neil Hawkins | Jeffrey S. Hoch

https://doi.org/10.1007/s40273-017-0583-4 Actions

Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JOURNAL ARTICLE published May 2018 in PharmacoEconomics

Research funded by National Institute for Health Research (Project number 15/121/14)

Authors: Keith Cooper | Geoff Frampton | Petra Harris | Micah Rose | Maria Chorozoglou | Karen Pickett

https://doi.org/10.1007/s40273-017-0608-z Actions

Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study

JOURNAL ARTICLE published March 2024 in PharmacoEconomics

Authors: Jason Gordon | Maria Gheorghe | Cale Harrison | Ryan Miller | James Dennis | Lotte Steuten | Simon Goldenberg | Sumanth Gandra | Amer Al-Taie

https://doi.org/10.1007/s40273-023-01337-9 Actions

Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA

JOURNAL ARTICLE published October 2022 in PharmacoEconomics

Authors: Jing Voon Chen | James C. Gahn | Jeffrey Nesheim | Paul N. Mudd,

https://doi.org/10.1007/s40273-022-01163-5 Actions

Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer’s Perspective

JOURNAL ARTICLE published December 2022 in PharmacoEconomics

Authors: Tingting Qu | Shujing Zhang | Yichen Zhong | Yang Meng | He Guo | Seongjung Joo | Peter C. Enzinger

https://doi.org/10.1007/s40273-022-01196-w Actions

Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer

JOURNAL ARTICLE published 2008 in PharmacoEconomics

Authors: Lieven Annemans

https://doi.org/10.2165/00019053-200826050-00005 Actions

Cost-Effectiveness of Diabetes Education

JOURNAL ARTICLE published 1995 in PharmacoEconomics

Authors: Jean-Philippe Assal

https://doi.org/10.2165/00019053-199500081-00015 Actions

Therapeutic Options in the Treatment of Multiple Myeloma

JOURNAL ARTICLE published October 1999 in PharmacoEconomics

Authors: Finn Wisløff | Nina Gulbrandsen | Erik Nord

https://doi.org/10.2165/00019053-199916040-00002 Actions

Glossary

JOURNAL ARTICLE published July 1996 in PharmacoEconomics

https://doi.org/10.2165/00019053-199610010-00011 Actions

The Pharmacoeconomics of HIV Disease

JOURNAL ARTICLE published March 1992 in PharmacoEconomics

Authors: Lorna A. Lynn | Kevin A. Schulman | John M. Eisenberg

https://doi.org/10.2165/00019053-199201030-00003 Actions

The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence

JOURNAL ARTICLE published November 2016 in PharmacoEconomics

Research funded by National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme (project number 13/169/01)

Authors: Eleftherios Sideris | Mark Corbett | Stephen Palmer | Nerys Woolacott | Laura Bojke

https://doi.org/10.1007/s40273-016-0419-7 Actions

Quality Control in the Regulation of Pharmaceuticals

JOURNAL ARTICLE published 2005 in PharmacoEconomics

Authors: Alan Maynard

https://doi.org/10.2165/00019053-200523050-00001 Actions

Letter From the Commissioner???s Office at the US FDA

JOURNAL ARTICLE published 2007 in PharmacoEconomics

Authors: John A Vernon

https://doi.org/10.2165/00019053-200725040-00001 Actions

Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer

JOURNAL ARTICLE published 2007 in PharmacoEconomics

Authors: Steven B Zeliadt | David F Penson

https://doi.org/10.2165/00019053-200725040-00004 Actions

Quality of Life, Health Status and Clinical Drug Research

JOURNAL ARTICLE published July 1992 in PharmacoEconomics

Authors: Supornchai Kongpatanakul | Brian L. Strom

https://doi.org/10.2165/00019053-199202010-00003 Actions

Clinical and Economic Factors Important to Anaesthetic Choice for Day-Case Surgery

JOURNAL ARTICLE published March 2000 in PharmacoEconomics

Authors: Edmond I. Eger | Paul F. White | Martin S. Bogetz

https://doi.org/10.2165/00019053-200017030-00003 Actions

Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain

JOURNAL ARTICLE published November 2006 in PharmacoEconomics

Authors: Arran T. Shearer | Adrian Bagust | F. Javier Ampudia-Blasco | Belén Martínez-Lage Álvarez | Isabel Pérez Escolano | Gonzalo París

https://doi.org/10.2165/00019053-200624001-00005 Actions

Cost Effectiveness and Allocation of Therapies in a Treating Population: The Author’s Reply

JOURNAL ARTICLE published June 1997 in PharmacoEconomics

Authors: Paul C. Langley

https://doi.org/10.2165/00019053-199711060-00009 Actions
Feedback: support@crossref.org